-
1
-
-
2942581416
-
Protein tyrosine phosphatases in the human genome
-
A. Alonso, J. Sasin, N. Bottini, I. Friedberg, A. Osterman, A. Godzik, T. Hunter, J. Dixon, T. Mustelin, Protein tyrosine phosphatases in the human genome, Cell 117 (2004) 699-711.
-
(2004)
Cell
, vol.117
, pp. 699-711
-
-
Alonso, A.1
Sasin, J.2
Bottini, N.3
Friedberg, I.4
Osterman, A.5
Godzik, A.6
Hunter, T.7
Dixon, J.8
Mustelin, T.9
-
2
-
-
0030953448
-
Protein tyrosine phosphatases in signal transduction
-
B.G. Neel, N.K. Tonks, Protein tyrosine phosphatases in signal transduction, Curr. Opin. Cell Biol. 9 (1997) 193-204.
-
(1997)
Curr. Opin. Cell Biol.
, vol.9
, pp. 193-204
-
-
Neel, B.G.1
Tonks, N.K.2
-
3
-
-
0034614490
-
Signaling-2000 and beyond
-
T. Hunter, Signaling-2000 and beyond, Cell 100 (2000) 113-127.
-
(2000)
Cell
, vol.100
, pp. 113-127
-
-
Hunter, T.1
-
4
-
-
0035313868
-
Combinatorial control of the specificity of protein tyrosine phosphatases
-
N.K. Tonks, B.G. Neel, Combinatorial control of the specificity of protein tyrosine phosphatases, Curr. Opin. Cell Biol. 13 (2001) 182-195.
-
(2001)
Curr. Opin. Cell Biol.
, vol.13
, pp. 182-195
-
-
Tonks, N.K.1
Neel, B.G.2
-
5
-
-
26444523586
-
Tyrosine phosphatases as regulators of skeletal development and metabolism
-
K.R. Schiller, L.J. Mauro, Tyrosine phosphatases as regulators of skeletal development and metabolism, J. Cell Biochem. 96 (2005) 262-277.
-
(2005)
J. Cell Biochem.
, vol.96
, pp. 262-277
-
-
Schiller, K.R.1
Mauro, L.J.2
-
6
-
-
0035902180
-
Oncogenic kinase signaling
-
P. Blume-Jensen, T. Hunter, Oncogenic kinase signaling, Nature 411 (2001) 355-365.
-
(2001)
Nature
, vol.411
, pp. 355-365
-
-
Blume-Jensen, P.1
Hunter, T.2
-
8
-
-
0036230536
-
Protein tyrosine phosphatase 1B: A potential leptin resistance factor of obesity
-
W.S. Cook, R.H. Unger, Protein tyrosine phosphatase 1B: a potential leptin resistance factor of obesity, Dev. Cell 2 (2002) 385-387.
-
(2002)
Dev. Cell
, vol.2
, pp. 385-387
-
-
Cook, W.S.1
Unger, R.H.2
-
9
-
-
0029810614
-
Protein-tyrosine phosphatase 1B is a negative regulator of insulin-and insulin-like growth factor-Istimulated signaling
-
K.A. Kenner, E. Anyanwu, J.M. Olefsky, J. Kusari, Protein-tyrosine phosphatase 1B is a negative regulator of insulin-and insulin-like growth factor-Istimulated signaling, J. Biol. Chem. 271 (1996) 19810-19816.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 19810-19816
-
-
Kenner, K.A.1
Anyanwu, E.2
Olefsky, J.M.3
Kusari, J.4
-
10
-
-
0031943479
-
Regulation of the insulin signaling pathway by cellular protein-tyrosine phosphatases
-
B.J. Goldstein, F. Ahmad, W. Ding, P.M. Li, W.R. Zhang, Regulation of the insulin signaling pathway by cellular protein-tyrosine phosphatases, Mol. Cell Biochem. 182 (1998) 91-99.
-
(1998)
Mol. Cell Biochem.
, vol.182
, pp. 91-99
-
-
Goldstein, B.J.1
Ahmad, F.2
Ding, W.3
Li, P.M.4
Zhang, W.R.5
-
11
-
-
0034308201
-
Protein tyrosine phosphatase-1B in diabetes
-
B.P. Kennedy, C. Ramachandran, Protein tyrosine phosphatase-1B in diabetes, Biochem. Pharmacol. 60 (2000) 877-883.
-
(2000)
Biochem. Pharmacol.
, vol.60
, pp. 877-883
-
-
Kennedy, B.P.1
Ramachandran, C.2
-
12
-
-
0033525870
-
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
-
M. Elchebly, P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, A.L. Loy, D. Normandin, A. Cheng, J. Himms-Hagen, C.C. Chan, C. Ramachandran, M.J. Gresser, M.L. Tremblay, B.P. Kennedy, Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene, Science 283 (1999) 1544-1548.
-
(1999)
Science
, vol.283
, pp. 1544-1548
-
-
Elchebly, M.1
Payette, P.2
Michaliszyn, E.3
Cromlish, W.4
Collins, S.5
Loy, A.L.6
Normandin, D.7
Cheng, A.8
Himms-Hagen, J.9
Chan, C.C.10
Ramachandran, C.11
Gresser, M.J.12
Tremblay, M.L.13
Kennedy, B.P.14
-
13
-
-
0033942614
-
Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice
-
L.D. Klaman, O. Boss, O.D. Peroni, J.K. Kim, J.L. Martino, J.M. Zabolotny, N. Moghal, M. Lubkin, Y.B. Kim, A.H. Sharpe, A. Stricker-Krongrad, G.I. Shulman, B.G. Neel, B.B. Kahn, Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice, Mol. Cell Biol. 20 (2000) 5479-5489.
-
(2000)
Mol. Cell Biol.
, vol.20
, pp. 5479-5489
-
-
Klaman, L.D.1
Boss, O.2
Peroni, O.D.3
Kim, J.K.4
Martino, J.L.5
Zabolotny, J.M.6
Moghal, N.7
Lubkin, M.8
Kim, Y.B.9
Sharpe, A.H.10
Stricker-Krongrad, A.11
Shulman, G.I.12
Neel, B.G.13
Kahn, B.B.14
-
14
-
-
0036329620
-
Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis
-
C.M. Rondinone, J.M. Trevillyan, J. Clampit, R.J. Gum, C. Berg, P. Kroeger, L. Frost, B.A. Zinker, R. Reilly, R. Ulrich, M. Butler, B.P. Monia, M.R. Jirousek, J.F. Waring, Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis, Diabetes 51 (2002) 2405-2411.
-
(2002)
Diabetes
, vol.51
, pp. 2405-2411
-
-
Rondinone, C.M.1
Trevillyan, J.M.2
Clampit, J.3
Gum, R.J.4
Berg, C.5
Kroeger, P.6
Frost, L.7
Zinker, B.A.8
Reilly, R.9
Ulrich, R.10
Butler, M.11
Monia, B.P.12
Jirousek, M.R.13
Waring, J.F.14
-
15
-
-
33646046143
-
Inhibition of protein tyrosine phosphatase 1B by diterpenoids isolated from Acanthopanax koreanum
-
M. Na, W.K. Oh, Y.H. Kim, X.F. Cai, S. Kim, B.Y. Kim, J.S. Ahn, Inhibition of protein tyrosine phosphatase 1B by diterpenoids isolated from Acanthopanax koreanum, Bioorg. Med. Chem. Lett. 16 (2006) 3061-3064.
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 3061-3064
-
-
Na, M.1
Oh, W.K.2
Kim, Y.H.3
Cai, X.F.4
Kim, S.5
Kim, B.Y.6
Ahn, J.S.7
-
16
-
-
0034785827
-
Structural and evolutionary relationships among protein tyrosine phosphatase domains
-
J.N. Andersen, O.H. Mortensen, G.H. Peters, P.G. Drake, L.F. Iversen, O.H. Olsen, H.S. Jansen, P.G. Andersen, N.K. Tonks, N.P.H. Moller, Structural and evolutionary relationships among protein tyrosine phosphatase domains, Mol. Cell Biol. 21 (2001) 7117-7136.
-
(2001)
Mol. Cell Biol.
, vol.21
, pp. 7117-7136
-
-
Andersen, J.N.1
Mortensen, O.H.2
Peters, G.H.3
Drake, P.G.4
Iversen, L.F.5
Olsen, O.H.6
Jansen, H.S.7
Andersen, P.G.8
Tonks, N.K.9
Moller, N.P.H.10
-
17
-
-
27144444772
-
Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics
-
A.P. Combs, E.W. Yue, M. Bower, P.J. Ala, B. Wayland, B. Douty, A. Takvorian, P. Polam, Z. Wasserman, W. Zhu, M.L. Crawley, J. Pruitt, R. Sparks, B. Glass, D. Modi, E. McLaughlin, L. Bostrom, M. Li, L. Galya, K. Blom, M.I. Hillman, L. Gonneville, B.G. Reid, M. Wei, M. Becker-Pasha, R. Klabe, R. Huber, Y. Li, G. Hollis, T.C. Burn, R. Wynn, P. Liu, B. Metcalf, Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics, J. Med. Chem. 48 (2005) 6544-6548.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 6544-6548
-
-
Combs, A.P.1
Yue, E.W.2
Bower, M.3
Ala, P.J.4
Wayland, B.5
Douty, B.6
Takvorian, A.7
Polam, P.8
Wasserman, Z.9
Zhu, W.10
Crawley, M.L.11
Pruitt, J.12
Sparks, R.13
Glass, B.14
Modi, D.15
McLaughlin, E.16
Bostrom, L.17
Li, M.18
Galya, L.19
Blom, K.20
Hillman, M.I.21
Gonneville, L.22
Reid, B.G.23
Wei, M.24
Becker-Pasha, M.25
Klabe, R.26
Huber, R.27
Li, Y.28
Hollis, G.29
Burn, T.C.30
Wynn, R.31
Liu, P.32
Metcalf, B.33
more..
-
19
-
-
0036928644
-
Protein tyrosine phosphatases as drug targets: PTP1B and beyond
-
R. Hooft van Huijsduijnen, S. Walchli, M. Ibberson, A. Harrenga, Protein tyrosine phosphatases as drug targets: PTP1B and beyond, Expert Opin. Ther. Targets 6 (2002) 637e647.
-
(2002)
Expert Opin. Ther. Targets
, vol.6
, pp. 637-647
-
-
Huijsduijnen Van R.Hooft1
Walchli, S.2
Ibberson, M.3
Harrenga, A.4
-
20
-
-
0034864263
-
Pulling strings below the surface. Hormone receptor signaling through inhibition of protein tyrosine phosphatases
-
X. Espanel, S. Walchli, R. Pescini-Gobert, M. El Alama, M.L. Curchod, N. Gullu-Isler, R. Hooft van Huijsduijnen, Pulling strings below the surface. Hormone receptor signaling through inhibition of protein tyrosine phosphatases, Endocrine 15 (2001) 19-28.
-
(2001)
Endocrine
, vol.15
, pp. 19-28
-
-
Espanel, X.1
Walchli, S.2
Pescini-Gobert, R.3
El Alama, M.4
Curchod, M.L.5
Gullu-Isler, N.6
Huijsduijnen Van R.Hooft7
-
21
-
-
0028231388
-
Crystal structure of human protein tyrosine phosphatase 1B
-
D. Barford, A.J. Flint, N.K. Tonks, Crystal structure of human protein tyrosine phosphatase 1B, Science 263 (1994) 1397-1404.
-
(1994)
Science
, vol.263
, pp. 1397-1404
-
-
Barford, D.1
Flint, A.J.2
Tonks, N.K.3
-
22
-
-
0032559056
-
-
M.R. Groves, Z.J. Yao, P.P. Roller, T.R. Burke Jr., D. Barford, Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics, Biochemistry 37 (1998) 17773-17783.
-
(1998)
Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics, Biochemistry
, vol.37
, pp. 17773-17783
-
-
Groves, M.R.1
Yao, Z.J.2
Roller, P.P.3
Burke, T.R.4
Barford, D.5
-
23
-
-
0037377337
-
Structurebased design and discovery of novel inhibitors of protein tyrosine phosphatases
-
P. Huang, J. Ramphal, J. Wei, C. Liang, B. Jallal, G. McMahon, C. Tang, Structurebased design and discovery of novel inhibitors of protein tyrosine phosphatases, Bioorg. Med. Chem. 11 (2003) 1835-1849.
-
(2003)
Bioorg. Med. Chem.
, vol.11
, pp. 1835-1849
-
-
Huang, P.1
Ramphal, J.2
Wei, J.3
Liang, C.4
Jallal, B.5
McMahon, G.6
Tang, C.7
-
24
-
-
0036079343
-
Recent discovery and development of protein tyrosine phosphatase inhibitors
-
M.A. Blaskovich, H.O. Kim, Recent discovery and development of protein tyrosine phosphatase inhibitors, Expert Opin. Ther. Pat. 12 (2002) 871-905.
-
(2002)
Expert Opin. Ther. Pat.
, vol.12
, pp. 871-905
-
-
Blaskovich, M.A.1
Kim, H.O.2
-
25
-
-
0141706651
-
The structural basis for the selectivity of benzotriazole inhibitors of PTP 1B
-
G. Scapin, S.B. Patel, J.W. Becker, Q. Wang, C. Desponts, D. Waddleton, K. Skorey, W. Cromlish, M. Bayly, C. Therien, J.Y. Gauthier, C.S. Li, C.K. Lau, C. Ramachandran, B.P. Kennedy, E. Asante-Appiah, The structural basis for the selectivity of benzotriazole inhibitors of PTP 1B, Biochemistry 42 (2003) 11451-11459.
-
(2003)
Biochemistry
, vol.42
, pp. 11451-11459
-
-
Scapin, G.1
Patel, S.B.2
Becker, J.W.3
Wang, Q.4
Desponts, C.5
Waddleton, D.6
Skorey, K.7
Cromlish, W.8
Bayly, M.9
Therien, C.10
Gauthier, J.Y.11
Li, C.S.12
Lau, C.K.13
Ramachandran, C.14
Kennedy, B.P.15
Asante-Appiah, E.16
-
26
-
-
18444370551
-
The structure of PTP1B in complex with a peptide inhibitor reveals an alternative binding mode for bisphosphonates
-
E. Asante-Appiah, S. Patel, C. Dufresne, P. Roy, Q. Wang, V. Patel, R.W. Friesen, C. Ramachandran, J.W. Becker, Y. Leblanc, B.P. Kennedy, G. Scapin, The structure of PTP1B in complex with a peptide inhibitor reveals an alternative binding mode for bisphosphonates, Biochemistry 41 (2002) 9043-9051.
-
(2002)
Biochemistry
, vol.41
, pp. 9043-9051
-
-
Asante-Appiah, E.1
Patel, S.2
Dufresne, C.3
Roy, P.4
Wang, Q.5
Patel, V.6
Friesen, R.W.7
Ramachandran, C.8
Becker, J.W.9
Leblanc, Y.10
Kennedy, B.P.11
Scapin, G.12
-
27
-
-
33845993617
-
Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B
-
P.J. Ala, L. Gonneville, M. Hillman, M. Becker-Pasha, E.W. Yue, B. Douty, B. Wayland, P. Polam, M.L. Crawley, E. McLaughlin, R.B. Sparks, B. Glass, A. Takvorian, A.P. Combs, T.C. Burn, G.F. Hollis, R. Wynn, Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B, J. Biol. Chem. 281 (2006) 38013-38021.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 38013-38021
-
-
Ala, P.J.1
Gonneville, L.2
Hillman, M.3
Becker-Pasha, M.4
Yue, E.W.5
Douty, B.6
Wayland, B.7
Polam, P.8
Crawley, M.L.9
McLaughlin, E.10
Sparks, R.B.11
Glass, B.12
Takvorian, A.13
Combs, A.P.14
Burn, T.C.15
Hollis, G.F.16
Wynn, R.17
-
28
-
-
77949845981
-
Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer
-
A.P. Combs, Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer, J. Med. Chem. 53 (2010) 2333-2344.
-
(2010)
J. Med. Chem.
, vol.53
, pp. 2333-2344
-
-
Combs, A.P.1
-
29
-
-
33745658606
-
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the hetero-cyclic (S)-isothiazolidinone phosphotyrosine mimetic
-
A.P. Combs, W. Zhu, M.L. Crawley, B. Glass, P. Polam, R.B. Sparks, D. Modi, A. Takvorian, E. McLaughlin, E.W. Yue, Z. Wasserman, M. Bower, M. Wei, M. Rupar, P.J. Ala, B.M. Reid, D. Ellis, L. Gonneville, T. Emm, N. Taylor, S. Yeleswaram, Y. Li, R. Wynn, T.C. Burn, G. Hollis, P.C. Liu, B. Metcalf, Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the hetero-cyclic (S)-isothiazolidinone phosphotyrosine mimetic, J. Med. Chem. 49 (2006) 3774e3789.
-
(2006)
J. Med. Chem.
, vol.49
, pp. 3774-3789
-
-
Combs, A.P.1
Zhu, W.2
Crawley, M.L.3
Glass, B.4
Polam, P.5
Sparks, R.B.6
Modi, D.7
Takvorian, A.8
McLaughlin, E.9
Yue, E.W.10
Wasserman, Z.11
Bower, M.12
Wei, M.13
Rupar, M.14
Ala, P.J.15
Reid, B.M.16
Ellis, D.17
Gonneville, L.18
Emm, T.19
Taylor, N.20
Yeleswaram, S.21
Li, Y.22
Wynn, R.23
Burn, T.C.24
Hollis, G.25
Liu, P.C.26
Metcalf, B.27
more..
-
30
-
-
34247362854
-
PTP1B as a drug target: Recent developments in PTP1B inhibitor discovery
-
S. Zhang, Z.Y. Zhang, PTP1B as a drug target: recent developments in PTP1B inhibitor discovery, Drug Discov. Today 12 (2007) 373e381.
-
(2007)
Drug Discov. Today
, vol.12
, pp. 373-381
-
-
Zhang, S.1
Zhang, Z.Y.2
-
31
-
-
34347260715
-
Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B
-
S. Lee, Q. Wang, Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B, Med. Res. Rev. 27 (2007) 553e573.
-
(2007)
Med. Res. Rev.
, vol.27
, pp. 553-573
-
-
Lee, S.1
Wang, Q.2
-
32
-
-
0036300139
-
Appetite suppression and weight reduction by a centrally active aminosterol
-
R.S. Ahima, H.R. Patel, N. Takahashi, Y. Qi, S.M. Hileman, M.A. Zasloff, Appetite suppression and weight reduction by a centrally active aminosterol, Diabetes 51 (2002) 2099-2104.
-
(2002)
Diabetes
, vol.51
, pp. 2099-2104
-
-
Ahima, R.S.1
Patel, H.R.2
Takahashi, N.3
Qi, Y.4
Hileman, S.M.5
Zasloff, M.A.6
-
33
-
-
0035021763
-
A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties
-
M. Zasloff, J.I. Williams, Q. Chen, M. Anderson, T. Maeder, S. Jones, W. Kinney, K. Cheshire, M. McLane, A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties, Int. J. Obes. Relat. Metab. Disord. 25 (2000) 689-697.
-
(2000)
Int. J. Obes. Relat. Metab. Disord.
, vol.25
, pp. 689-697
-
-
Zasloff, M.1
Williams, J.I.2
Chen, Q.3
Anderson, M.4
Maeder, T.5
Jones, S.6
Kinney, W.7
Cheshire, K.8
McLane, M.9
-
34
-
-
4344566976
-
A novel aminosterol reverses diabetes and fatty liver disease in obese mice
-
N. Takahashi, Y. Qi, H.R. Patel, R.S. Ahima, A novel aminosterol reverses diabetes and fatty liver disease in obese mice, J. Hepetol. 41 (2004) 391-398.
-
(2004)
J. Hepetol.
, vol.41
, pp. 391-398
-
-
Takahashi, N.1
Qi, Y.2
Patel, H.R.3
Ahima, R.S.4
-
35
-
-
77955052291
-
Inhibition of PTP1B by trodusquemine (MSI-1436) causes fatspecific weight loss in diet-induced obese mice
-
K.A. Lantz, S.G. Hart, S.L. Planey, M.F. Roitman, I.A. Ruiz-White, H.R. Wolfe, M.P. McLane, Inhibition of PTP1B by trodusquemine (MSI-1436) causes fatspecific weight loss in diet-induced obese mice, Obesity 8 (2010) 1516-1523.
-
(2010)
Obesity
, vol.8
, pp. 1516-1523
-
-
Lantz, K.A.1
Hart, S.G.2
Planey, S.L.3
Roitman, M.F.4
Ruiz-White, I.A.5
Wolfe, H.R.6
McLane, M.P.7
-
36
-
-
79957875786
-
Pharmacophore modelling, molecular docking and virtual screening for EGFR (HER 1) tyrosine kinase inhibitors
-
A.K. Gupta, S.S. Bhunia, V.M. Balaramnavar, A.K. Saxena, Pharmacophore modelling, molecular docking and virtual screening for EGFR (HER 1) tyrosine kinase inhibitors, SAR QSAR Environ. Res. 3 (2011) 239-263.
-
(2011)
SAR QSAR Environ. Res.
, vol.3
, pp. 239-263
-
-
Gupta, A.K.1
Bhunia, S.S.2
Balaramnavar, V.M.3
Saxena, A.K.4
-
37
-
-
77956324497
-
Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: Pharmacophore-based virtual screening synthesis and pharmacology
-
S.S. Chaudhaery, K.K. Roy, N. Shakya, G. Saxena, S.R. Sammi, A. Nazir, C. Nath, A.K. Saxena, Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology, J. Med. Chem. 53 (2010) 6490-6505.
-
(2010)
J. Med. Chem.
, vol.53
, pp. 6490-6505
-
-
Chaudhaery, S.S.1
Roy, K.K.2
Shakya, N.3
Saxena, G.4
Sammi, S.R.5
Nazir, A.6
Nath, C.7
Saxena, A.K.8
-
38
-
-
79961217268
-
Tryptophan 2, 3-dioxygenase (TDO) inhibitors. 3-(2-(Pyridyl) ethenyl) indoles as potential anticancer immunomodulators
-
E. Dolusic, P. Larrieu, L. Moineaux, V. Stroobant, L. Pilotte, D. Colau, L. Pochet, B. Van den Eynde, B. Masereel, J. Wouters, R. Frederick, Tryptophan 2, 3-dioxygenase (TDO) inhibitors. 3-(2-(Pyridyl) ethenyl) indoles as potential anticancer immunomodulators, J. Med. Chem. 54 (2011) 5320-5334.
-
(2011)
J. Med. Chem.
, vol.54
, pp. 5320-5334
-
-
Dolusic, E.1
Larrieu, P.2
Moineaux, L.3
Stroobant, V.4
Pilotte, L.5
Colau, D.6
Pochet, L.7
Eynde Den B.Van8
Masereel, B.9
Wouters, J.10
Frederick, R.11
-
39
-
-
84901649734
-
Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansionand improves dyslipidemia in vivo
-
S. Varshney, K. Shankar, M. Beg, V.M. Balaramnavar, S.K. Mishra, P. Jagdale, S. Srivastava, Y.S. Chhonker, V. Lakshmi, B.P. Chaudhari, R.S. Bhatta, A.K. Saxena, A.N. Gaikwad, Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansionand improves dyslipidemia in vivo, J. Lipid Res. (2014), http://dx.doi.org/10.1194/jlr.M039925.
-
(2014)
J. Lipid Res.
-
-
Varshney, S.1
Shankar, K.2
Beg, M.3
Balaramnavar, V.M.4
Mishra, S.K.5
Jagdale, P.6
Srivastava, S.7
Chhonker, Y.S.8
Lakshmi, V.9
Chaudhari, B.P.10
Bhatta, R.S.11
Saxena, A.K.12
Gaikwad, A.N.13
-
40
-
-
34250332663
-
Computer-aided drug design: Integration of structure-based and ligand-based approaches in drug design
-
P. Prathipati, A. Dixit, A.K. Saxena, Computer-aided drug design: integration of structure-based and ligand-based approaches in drug design, Curr. Comp. Aided Drug Des. 3 (2007) 133-148.
-
(2007)
Curr. Comp. Aided Drug Des.
, vol.3
, pp. 133-148
-
-
Prathipati, P.1
Dixit, A.2
Saxena, A.K.3
-
41
-
-
0027944195
-
Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity
-
G. Klebe, U. Abraham, T. Mietzner, Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity, J. Med. Chem. 37 (1994) 4130-4146.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 4130-4146
-
-
Klebe, G.1
Abraham, U.2
Mietzner, T.3
-
42
-
-
0033022163
-
Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries
-
G. Klebe, U. Abraham, Comparative molecular similarity index analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries, J. Comput. Aided Mol. Des. 13 (1999) 1-10.
-
(1999)
J. Comput. Aided Mol. Des.
, vol.13
, pp. 1-10
-
-
Klebe, G.1
Abraham, U.2
-
44
-
-
0037837211
-
Development of biologically active compounds by combining 3D QSAR and structure-based design methods
-
W. Sippl, Development of biologically active compounds by combining 3D QSAR and structure-based design methods, J. Comput. Aided Mol. Des. 16 (2002) 825-830.
-
(2002)
J. Comput. Aided Mol. Des.
, vol.16
, pp. 825-830
-
-
Sippl, W.1
-
45
-
-
0037763817
-
Comparative evaluation of 11 scoring functions for molecular docking
-
R. Wang, Y. Lu, S. Wang, Comparative evaluation of 11 scoring functions for molecular docking, J. Med. Chem. 46 (2003) 2287-2303.
-
(2003)
J. Med. Chem.
, vol.46
, pp. 2287-2303
-
-
Wang, R.1
Lu, Y.2
Wang, S.3
-
46
-
-
2942720960
-
Impact of scoring functions on enrichment in dockingbased virtual screening: An application study on renin inhibitors
-
E.M. Krovat, T. Langer, Impact of scoring functions on enrichment in dockingbased virtual screening: an application study on renin inhibitors, J. Chem. Inf. Comput. Sci. 44 (2004) 1123-1129.
-
(2004)
J. Chem. Inf. Comput. Sci.
, vol.44
, pp. 1123-1129
-
-
Krovat, E.M.1
Langer, T.2
-
47
-
-
33748667774
-
Consensus scoring for proteineligand interactions
-
M. Feher, Consensus scoring for proteineligand interactions, Drug Discov. Today 11 (2006) 421-428.
-
(2006)
Drug Discov. Today
, vol.11
, pp. 421-428
-
-
Feher, M.1
-
48
-
-
33845362773
-
Structure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method
-
C. Michaux, X. de Leval, F. Julemont, J.M. Dogne, B. Pirotte, F. Durant, Structure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method, Eur. J. Med. Chem. 41 (2006) 1446-1455.
-
(2006)
Eur. J. Med. Chem.
, vol.41
, pp. 1446-1455
-
-
Michaux, C.1
De Leval, X.2
Julemont, F.3
Dogne, J.M.4
Pirotte, B.5
Durant, F.6
-
49
-
-
33745221417
-
The discovery of new 11b-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening
-
D. Schuster, E.M. Maurer, C. Laggner, L.G. Nashev, T. Wilckens, T. Langer, A. Odermatt, The discovery of new 11b-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening, J. Med. Chem. 49 (2006) 3454-3466.
-
(2006)
J. Med. Chem.
, vol.49
, pp. 3454-3466
-
-
Schuster, D.1
Maurer, E.M.2
Laggner, C.3
Nashev, L.G.4
Wilckens, T.5
Langer, T.6
Odermatt, A.7
-
50
-
-
23844457000
-
Discovery of high-affinity ligands of s1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening
-
C. Laggner, C. Schieferer, B. Fiechtner, G. Poles, R.D. Hoffmann, H. Glossmann, T. Langer, F.F. Moebius, Discovery of high-affinity ligands of s1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening, J. Med. Chem. 48 (2005) 4754-4764.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 4754-4764
-
-
Laggner, C.1
Schieferer, C.2
Fiechtner, B.3
Poles, G.4
Hoffmann, R.D.5
Glossmann, H.6
Langer, T.7
Moebius, F.F.8
-
51
-
-
21244446301
-
A three dimensional pharmacophore model for 5-Hydroxytryptamine 6 (5-HT6) receptor antagonists
-
M.L. Lopez-Rodriguez, B. Benhamu, T. de la Fuente, A. Sanz, L. Pardo, M. Campillo, A three dimensional pharmacophore model for 5-Hydroxytryptamine 6 (5-HT6) receptor antagonists, J. Med. Chem. 48 (2005) 4216-4219.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 4216-4219
-
-
Lopez-Rodriguez, M.L.1
Benhamu, B.2
De La Fuente, T.3
Sanz, A.4
Pardo, L.5
Campillo, M.6
-
52
-
-
5644236834
-
Pharmacophore modeling and three dimensional database searching for drug design using catalyst: Recent advances
-
O. Guner, O. Clement, Y. Kurogi, Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances, Curr. Med. Chem. 11 (2004) 2991-3005.
-
(2004)
Curr. Med. Chem.
, vol.11
, pp. 2991-3005
-
-
Guner, O.1
Clement, O.2
Kurogi, Y.3
-
53
-
-
0019139731
-
The binding sites on human serum albumin for some nonsteroidal antiinflammatory drugs
-
A. Kober, I. Sjoholm, The binding sites on human serum albumin for some nonsteroidal antiinflammatory drugs, Mol. Pharmacol. 18 (1980) 421e426.
-
(1980)
Mol. Pharmacol.
, vol.18
, pp. 421-426
-
-
Kober, A.1
Sjoholm, I.2
-
54
-
-
0019538149
-
Molecular aspects of ligand binding to serum albumin
-
U. Kragh-Hansen, Molecular aspects of ligand binding to serum albumin, Pharmacol. Rev. 33 (1981) 17-53.
-
(1981)
Pharmacol. Rev.
, vol.33
, pp. 17-53
-
-
Kragh-Hansen, U.1
-
55
-
-
0019524375
-
The location of drug binding sites in human serum albumin
-
K.J. Fehske, W.E. Müller, U. Wollert, The location of drug binding sites in human serum albumin, Biochem. Pharmacol. 30 (1981) 687-692.
-
(1981)
Biochem. Pharmacol.
, vol.30
, pp. 687-692
-
-
Fehske, K.J.1
Müller, W.E.2
Wollert, U.3
-
56
-
-
77952951123
-
Hydrophobization of bovine serum albumin with cationic surfactants with different hydrophobic chain length
-
R. Kun, L. Kis, I. Dekany, Hydrophobization of bovine serum albumin with cationic surfactants with different hydrophobic chain length, Colloids Surf. B Biointerfaces 79 (2010) 61-68.
-
(2010)
Colloids Surf. B Biointerfaces
, vol.79
, pp. 61-68
-
-
Kun, R.1
Kis, L.2
Dekany, I.3
-
57
-
-
77949490963
-
Spectroscopic studies on the interaction and sonodynamic damage of neutral red (NR) to bovine serum albumin (BSA)
-
B. Liu, Y. Guo, J. Wang, R. Xu, X. Wang, D. Wanga, L. Zhanga, Y. Xuc, Spectroscopic studies on the interaction and sonodynamic damage of neutral red (NR) to bovine serum albumin (BSA), J. Lumin. 130 (2010) 1036-1043.
-
(2010)
J. Lumin.
, vol.130
, pp. 1036-1043
-
-
Liu, B.1
Guo, Y.2
Wang, J.3
Xu, R.4
Wang, X.5
Wanga, D.6
Zhanga, L.7
Xuc, Y.8
-
58
-
-
34548152571
-
Nitroaniline isomers interaction with bovine serum albumin and toxicological implications
-
G.H. Xiang, C.L. Tong, H.Z. Lin, Nitroaniline isomers interaction with bovine serum albumin and toxicological implications, J. Fluoresc. 17 (2007) 512e521.
-
(2007)
J. Fluoresc.
, vol.17
, pp. 512-521
-
-
Xiang, G.H.1
Tong, C.L.2
Lin, H.Z.3
-
59
-
-
0034287494
-
Spectroscopic studies on the interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants
-
E.L. Gelamo, M. Tabak, Spectroscopic studies on the interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants, Spectrochim. Acta A Mol. Biomol. Spectrosc. 56A (2000) 2255-2271.
-
(2000)
Spectrochim. Acta A Mol. Biomol. Spectrosc.
, vol.56 A
, pp. 2255-2271
-
-
Gelamo, E.L.1
Tabak, M.2
-
60
-
-
0031457541
-
Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design
-
Y.A. Puius, Y. Zhao, M. Sullivan, D.S. Lawrence, S.C. Almo, Z.Y. Zhang, Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13420-13425.
-
(1997)
Proc. Natl. Acad. Sci. U. S. A.
, vol.94
, pp. 13420-13425
-
-
Puius, Y.A.1
Zhao, Y.2
Sullivan, M.3
Lawrence, D.S.4
Almo, S.C.5
Zhang, Z.Y.6
-
61
-
-
41849149691
-
PTP1B inhibitors: Synthesis and evaluation of difluoromethylenephosphonate bioisosteres on a sulfonamide scaffold
-
C.P. Holmes, X. Li, Y. Pan, C. Xu, A. Bhandari, C.M. Moody, J.A. Miguel, S.W. Ferla, M.N. De Francisco, B.T. Frederick, S. Zhou, N. Macher, L. Jang, J.D. Irvine, J.R. Grove, PTP1B inhibitors: synthesis and evaluation of difluoromethylenephosphonate bioisosteres on a sulfonamide scaffold, Bioorg. Med. Chem. Lett. 18 (2008) 2719-2724.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 2719-2724
-
-
Holmes, C.P.1
Li, X.2
Pan, Y.3
Xu, C.4
Bhandari, A.5
Moody, C.M.6
Miguel, J.A.7
Ferla, S.W.8
De Francisco, M.N.9
Frederick, B.T.10
Zhou, S.11
MacHer, N.12
Jang, L.13
Irvine, J.D.14
Grove, J.R.15
-
62
-
-
23944466408
-
Discovery and structure-activity relationships of novel sulfonamides as potent PTP1B inhibitors
-
C.P. Holmes, X. Li, Y. Pan, C. Xu, A. Bhandari, C.M.Moody, J.A. Miguel, S.W. Ferla, M.N. De Francisco, B.T. Frederick, S. Zhou, N. Macher, L. Jang, J.D. Irvine, J.R. Grove, Discovery and structure-activity relationships of novel sulfonamides as potent PTP1B inhibitors, Bioorg. Med. Chem. Lett. 15 (2005) 4336-4341.
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 4336-4341
-
-
Holmes, C.P.1
Li, X.2
Pan, Y.3
Xu, C.4
Bhandari, A.5
Moody, C.M.6
Miguel, J.A.7
Ferla, S.W.8
De Francisco, M.N.9
Frederick, B.T.10
Zhou, S.11
MacHer, N.12
Jang, L.13
Irvine, J.D.14
Grove, J.R.15
-
63
-
-
84907937016
-
Synthesis and molecular lipophilicity potential profiles of 1-[(3-methylphenyl) piperazin-1-yl]-3-[thio(4-acetamido)phenyl]propane : A potential hypotensive agents
-
J. Rao, R.C. Srimal, E. Audry, A. Carpy, A.K. Saxena, Synthesis and molecular lipophilicity potential profiles of 1-[(3-methylphenyl) piperazin-1-yl]-3-[thio(4-acetamido)phenyl]propane : a potential hypotensive agents, Chem-Inform 22 (1991) 200.
-
(1991)
Chem-Inform
, vol.22
, pp. 200
-
-
Rao, J.1
Srimal, R.C.2
Audry, E.3
Carpy, A.4
Saxena, A.K.5
-
64
-
-
0024993946
-
Synthesis biological evaluation and QSAR analysis of b-aroylaminoethyl and b-arylpropionamidopiperazines/piperidines/-pyrazinopyridoindoles/pyrazinoisoquinolines. A new class of potent H1-antagonists
-
M. Saxena, S.K. Agarwal, G.K. Patnaik, A.K. Saxena, Synthesis, biological evaluation and QSAR analysis of b-aroylaminoethyl and b-arylpropionamidopiperazines/piperidines/-pyrazinopyridoindoles/pyrazinoisoquinolines. A new class of potent H1-antagonists, J. Med. Chem. 33 (1990) 2970-2976.
-
(1990)
J. Med. Chem.
, vol.33
, pp. 2970-2976
-
-
Saxena, M.1
Agarwal, S.K.2
Patnaik, G.K.3
Saxena, A.K.4
-
65
-
-
0004565548
-
Identification of a pharmacophore by application of hypothetical active site lattice (HASL) approach
-
A.K. Saxena, M. Saxena, H. Chi, M. Wiese, Identification of a pharmacophore by application of hypothetical active site lattice (HASL) approach, Med. Chem. Res. 3 (1993) 201-208.
-
(1993)
Med. Chem. Res.
, vol.3
, pp. 201-208
-
-
Saxena, A.K.1
Saxena, M.2
Chi, H.3
Wiese, M.4
-
66
-
-
84867350005
-
Identification of novel 2-((1-(benzyl(2-hydroxy-2-phenylethyl) amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)benzoic acid analogues as BMP-2 stimulators
-
V.M. Balaramnavar, I.A. Khan, J.A. Siddiqui, M.P. Khan, B. Chakravarti, K. Sharan, G. Swarnkar, N. Rastogi, H.H. Siddiqui, D.P. Mishra, N. Chattopadhyay, A.K. Saxena, Identification of novel 2-((1-(benzyl(2-hydroxy-2-phenylethyl) amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)benzoic acid analogues as BMP-2 stimulators, J. Med. Chem. 55 (2012) 8248-8259.
-
(2012)
J. Med. Chem.
, vol.55
, pp. 8248-8259
-
-
Balaramnavar, V.M.1
Khan, I.A.2
Siddiqui, J.A.3
Khan, M.P.4
Chakravarti, B.5
Sharan, K.6
Swarnkar, G.7
Rastogi, N.8
Siddiqui, H.H.9
Mishra, D.P.10
Chattopadhyay, N.11
Saxena, A.K.12
-
67
-
-
80054780828
-
Synthesis and 2D QSAR of Osulphonated b-aminols derivatives as novel antifungal and antibacterial agents
-
S. Sharma, A.K. Pandey, P.K. Shukla, A.K. Saxena, Synthesis and 2D QSAR of Osulphonated b-aminols derivatives as novel antifungal and antibacterial agents, Bioorg. Med. Chem. Lett. 21 (2011) 6476-6481.
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 6476-6481
-
-
Sharma, S.1
Pandey, A.K.2
Shukla, P.K.3
Saxena, A.K.4
-
68
-
-
84856210291
-
Antidiabetic and antidyslipidemic activities of C. Cyminum L. In validated animal models
-
R. Srivastava, S.P. Srivastava, N. Jaiswal, A. Mishra, R. Maurya, A.K. Srivastava, Antidiabetic and antidyslipidemic activities of C. cyminum L. in validated animal models, Med. Chem. Res. 20 (2011) 1656-1666.
-
(2011)
Med. Chem. Res.
, vol.20
, pp. 1656-1666
-
-
Srivastava, R.1
Srivastava, S.P.2
Jaiswal, N.3
Mishra, A.4
Maurya, R.5
Srivastava, A.K.6
-
69
-
-
0034604684
-
Down-regulation of insulin signaling by protein-tyrosine phosphatase 1B is mediated by an N-terminal binding region
-
S. Dadke, J. Kusari, J. Chernoff, Down-regulation of insulin signaling by protein-tyrosine phosphatase 1B is mediated by an N-terminal binding region, J. Biol. Chem. 275 (2000) 23642-23647.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 23642-23647
-
-
Dadke, S.1
Kusari, J.2
Chernoff, J.3
-
70
-
-
0001489445
-
Tyrosine-specific protein kinase activity is associated with the purified insulin receptor
-
M. Kasuga, Y. Fujita-Yamaguchi, D.L. Blithe, C.R. Kahn, Tyrosine-specific protein kinase activity is associated with the purified insulin receptor, Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 2137-2141.
-
(1983)
Proc. Natl. Acad. Sci. U. S. A.
, vol.80
, pp. 2137-2141
-
-
Kasuga, M.1
Fujita-Yamaguchi, Y.2
Blithe, D.L.3
Kahn, C.R.4
-
71
-
-
0029908016
-
Expression of a constitutively active Akt/Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation
-
A.D. Kohn, S.A. Summers, M.J. Birnbaum, R.A. Roth, Expression of a constitutively active Akt/Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation, J. Biol. Chem. 271 (1996) 31372e31378.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 31372-31378
-
-
Kohn, A.D.1
Summers, S.A.2
Birnbaum, M.J.3
Roth, R.A.4
-
72
-
-
0031809969
-
Fructose uptake in rat adipocytes: Glut5 expression and the effects of streptozotocin-induced diabetes
-
E. Hajduch, F. Darakhshan, H.S. Hundal, Fructose uptake in rat adipocytes: glut5 expression and the effects of streptozotocin-induced diabetes, Diabetologia 41 (1998) 821-828.
-
(1998)
Diabetologia
, vol.41
, pp. 821-828
-
-
Hajduch, E.1
Darakhshan, F.2
Hundal, H.S.3
-
73
-
-
14944381279
-
Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications
-
J. Zdychova, R. Komers, Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications, Physiol. Res. 54 (2005) 1-16.
-
(2005)
Physiol. Res.
, vol.54
, pp. 1-16
-
-
Zdychova, J.1
Komers, R.2
-
74
-
-
84879621442
-
AMPK, insulin resistance, and the metabolic syndrome
-
N.B. Ruderman, D. Carling, M. Prentki, J.M. Cacicedo, AMPK, insulin resistance, and the metabolic syndrome, J. Clin. Invest 123 (2013) 2764-2772.
-
(2013)
J. Clin. Invest
, vol.123
, pp. 2764-2772
-
-
Ruderman, N.B.1
Carling, D.2
Prentki, M.3
Cacicedo, J.M.4
-
75
-
-
65349177200
-
AMPK: An emerging drug target for diabetes and the metabolic syndrome
-
B.B. Zhang, G. Zhou, C. Li, AMPK: an emerging drug target for diabetes and the metabolic syndrome, Cell Metab. 5 (2009) 407-416.
-
(2009)
Cell Metab.
, vol.5
, pp. 407-416
-
-
Zhang, B.B.1
Zhou, G.2
Li, C.3
-
76
-
-
84899520831
-
PPARs and metabolic syndrome
-
L. Chen, Z. Jia, G. Yang, PPARs and metabolic syndrome. PPAR Res. http://dx.doi.org/10.1155/2014/832606.
-
PPAR Res.
-
-
Chen, L.1
Jia, Z.2
Yang, G.3
-
77
-
-
1942518840
-
PPARs and the complex journey to obesity
-
R.M. Evans, G.D. Barish, Y.X. Wang, PPARs and the complex journey to obesity, Nat. Med. 4 (2004) 355-361.
-
(2004)
Nat. Med.
, vol.4
, pp. 355-361
-
-
Evans, R.M.1
Barish, G.D.2
Wang, Y.X.3
-
78
-
-
33746802788
-
Monocyclic thiophenes as protein tyrosine phosphatase1B inhibitors: Capturing interactions with Asp48
-
Z.K. Wan, J. Lee, W. Xu, D.V. Erbe, D. Joseph-McCarthy, B.C. Follows, Y.L. Zhang, Monocyclic thiophenes as protein tyrosine phosphatase1B inhibitors: capturing interactions with Asp48, Bioorg. Med. Chem. Lett. 16 (2006) 4941-4945.
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 4941-4945
-
-
Wan, Z.K.1
Lee, J.2
Xu, W.3
Erbe, D.V.4
Joseph-Mccarthy, D.5
Follows, B.C.6
Zhang, Y.L.7
-
79
-
-
32944477948
-
Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors
-
A.F. Moretto, S.J. Kirincich, W.X. Xu, M.J. Smith, Z.K. Wan, D.P. Wilson, B.C. Follows, E. Binnun, D. Joseph-McCarthy, K. Foreman, D.V. Erbe, Y.L. Zhang, S.K. Tam, S.Y. Tama, J. Leea, Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors, Bioorg. Med. Chem. 14 (2006) 2162-2177.
-
(2006)
Bioorg. Med. Chem.
, vol.14
, pp. 2162-2177
-
-
Moretto, A.F.1
Kirincich, S.J.2
Xu, W.X.3
Smith, M.J.4
Wan, Z.K.5
Wilson, D.P.6
Follows, B.C.7
Binnun, E.8
Joseph-Mccarthy, D.9
Foreman, K.10
Erbe, D.V.11
Zhang, Y.L.12
Tam, S.K.13
Tama, S.Y.14
Leea, J.15
-
80
-
-
34648833338
-
Structurebased optimization of protein tyrosine phosphatase 1B inhibitors: From the active site to the second phosphotyrosine binding site
-
D.P. Wilson, Z.K. Wan, W.X. Xu, S.J. Kirincich, B.C. Follows, D. Joseph-McCarthy, K. Foreman, A. Moretto, J. Wu, M. Zhu, E. Binnun, Y.L. Zhang, M. Tam, D.V. Erbe, J. Tobin, X. Xu, L. Leung, A. Shilling, S.Y. Tam, T.S. Mansour, J. Lee, Structurebased optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site, J. Med. Chem. 50 (2007) 4681-4698.
-
(2007)
J. Med. Chem.
, vol.50
, pp. 4681-4698
-
-
Wilson, D.P.1
Wan, Z.K.2
Xu, W.X.3
Kirincich, S.J.4
Follows, B.C.5
Joseph-Mccarthy, D.6
Foreman, K.7
Moretto, A.8
Wu, J.9
Zhu, M.10
Binnun, E.11
Zhang, Y.L.12
Tam, M.13
Erbe, D.V.14
Tobin, J.15
Xu, X.16
Leung, L.17
Shilling, A.18
Tam, S.Y.19
Mansour, T.S.20
Lee, J.21
more..
-
81
-
-
34247376964
-
Probing acid replacement of thiophene PTP1B inhibitors
-
Z.K. Wan, B. Follows, S. Kirincich, D. Wilson, E. Binnun, W. Xu, D. Joseph-McCarthy, J. Wu, M. Smith, Y.L. Zhang, M. Tam, D. Erbe, S. Tam, E. Saiah, J. Lee, Probing acid replacement of thiophene PTP1B inhibitors, Bioorg. Med. Chem. 17 (2007) 2913-2920.
-
(2007)
Bioorg. Med. Chem.
, vol.17
, pp. 2913-2920
-
-
Wan, Z.K.1
Follows, B.2
Kirincich, S.3
Wilson, D.4
Binnun, E.5
Xu, W.6
Joseph-Mccarthy, D.7
Wu, J.8
Smith, M.9
Zhang, Y.L.10
Tam, M.11
Erbe, D.12
Tam, S.13
Saiah, E.14
Lee, J.15
-
82
-
-
33744826819
-
MolDock: A new technique for high-accuracy molecular docking
-
R. Thomsen, M.H. Christensen, MolDock: a new technique for high-accuracy molecular docking, J. Med. Chem. 49 (2006) 3315-3321.
-
(2006)
J. Med. Chem.
, vol.49
, pp. 3315-3321
-
-
Thomsen, R.1
Christensen, M.H.2
-
83
-
-
0031552362
-
Development and validation of a genetic algorithm for flexible docking
-
G. Jones, P. Willett, R.C. Glen, A.R. Leach, R. Taylor, Development and validation of a genetic algorithm for flexible docking, J. Mol. Biol. 267 (1997) 727-748.
-
(1997)
J. Mol. Biol.
, vol.267
, pp. 727-748
-
-
Jones, G.1
Willett, P.2
Glen, R.C.3
Leach, A.R.4
Taylor, R.5
|